Machaon M Bonafede

Summary

Affiliation: Thomson Reuters
Country: UK

Publications

  1. pmc A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
    Machaon Mk Bonafede
    Thomson Reuters Inc, Cambridge, Massachusetts, USA
    Patient Prefer Adherence 4:147-56. 2010
  2. pmc Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
    Daniel Polsky
    Perelman School of Medicine and the Wharton School, University of Pennsylvania, Philadelphia, PA, USA
    BMC Health Serv Res 12:379. 2012
  3. doi Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings
    Machaon Bonafede
    Thomson Reuters, 37 Lowell Street, Andover, MA, USA
    Adv Ther 29:664-74. 2012
  4. doi Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation
    Machaon M K Bonafede
    J Med Econ 15:635-43. 2012
  5. doi Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study
    Machaon M K Bonafede
    Thomson Reuters Healthcare, Cambridge, Massachusetts, USA
    Clin Ther 34:457-67. 2012
  6. doi Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis
    Machaon M K Bonafede
    Thomson Reuters, Cambridge, MA, USA
    Adv Ther 29:234-48. 2012
  7. doi Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome
    Machaon Bonafede
    Thomson Reuters, Andover, MA, USA
    Hosp Pract (1995) 39:16-22. 2011
  8. pmc Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters Inc, 37 Lowell Street, Andover MA 01810, USA
    BMC Endocr Disord 11:3. 2011
  9. pmc Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
    Barbara H Johnson
    Life Sciences, Truven Health Analytics, 150 Cambridge Park Drive, Cambridge, MA, 02140, USA
    CNS Drugs 29:503-10. 2015
  10. ncbi Incidence and cost of CAP in a large working-age population
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters, Cambridge, MA, USA
    Am J Manag Care 18:380-7. 2012

Collaborators

Detail Information

Publications10

  1. pmc A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
    Machaon Mk Bonafede
    Thomson Reuters Inc, Cambridge, Massachusetts, USA
    Patient Prefer Adherence 4:147-56. 2010
    ..To describe insulin persistence among patients with type 2 diabetes initiating insulin therapy with basal insulin or insulin mixtures and determine factors associated with nonpersistence...
  2. pmc Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
    Daniel Polsky
    Perelman School of Medicine and the Wharton School, University of Pennsylvania, Philadelphia, PA, USA
    BMC Health Serv Res 12:379. 2012
    ..S. commercially-insured working age population...
  3. doi Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings
    Machaon Bonafede
    Thomson Reuters, 37 Lowell Street, Andover, MA, USA
    Adv Ther 29:664-74. 2012
    ....
  4. doi Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation
    Machaon M K Bonafede
    J Med Econ 15:635-43. 2012
    ....
  5. doi Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study
    Machaon M K Bonafede
    Thomson Reuters Healthcare, Cambridge, Massachusetts, USA
    Clin Ther 34:457-67. 2012
    ....
  6. doi Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis
    Machaon M K Bonafede
    Thomson Reuters, Cambridge, MA, USA
    Adv Ther 29:234-48. 2012
    ..This paper aims to estimate the annual cost of etanercept, adalimumab, and infliximab per treated patient across adult indications using US-managed care drug use data...
  7. doi Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome
    Machaon Bonafede
    Thomson Reuters, Andover, MA, USA
    Hosp Pract (1995) 39:16-22. 2011
    ..This study used real-world data to quantify the direct medical costs of dyspnea among patients with a history of ACS...
  8. pmc Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters Inc, 37 Lowell Street, Andover MA 01810, USA
    BMC Endocr Disord 11:3. 2011
    ..abstract:..
  9. pmc Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
    Barbara H Johnson
    Life Sciences, Truven Health Analytics, 150 Cambridge Park Drive, Cambridge, MA, 02140, USA
    CNS Drugs 29:503-10. 2015
    ..Multiple sclerosis (MS) registry data, primarily from Europe, suggest that treatment with natalizumab delays time to relapse compared with platform therapy (interferon beta/glatiramer acetate)...
  10. ncbi Incidence and cost of CAP in a large working-age population
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters, Cambridge, MA, USA
    Am J Manag Care 18:380-7. 2012
    ..To estimate incidence rates and quantify excess medical and productivity cost of community-acquired pneumonia (CAP) in a commercially insured, working-age population...